Cytodyn Inc (CYDY)

[Saltz]

No question lack of buyers is the other factor depressing SP. Financing/partnership/licensing deal is needed to break the cycle.
So what event will produce such a deal?

I strongly believe the tipping point we are looking for is somewhere in the interim results of the Mono Trial. It will be easy to enroll patients unlike the Combo Trial, and Mono with no SAE’s and 90% plus efficacy can’t be ignored. BP is content to wait and watch and hope we are unsuccessful. Meanwhile we are waiting for protocol approval from the FDA to begin this last leg strapped financially. This trial can’t happen fast enough as it will determine Leronlimab’s value in the HIV market.

We desperately need a $50-$100 million deal so we can expedite the BLA, Pivotal P3 Mono and TNBC trials. We are crawling due to lack of funds. There is no urgency to buy because we are STILL in the wait and see phase.

$ is the only factor creating a barrier. It’s such a catch 22 and BP knows exactly what our predicament is. So close but yet so far.